Azithromycin suppresses CD4+ T-cell activation by direct modulation of mTOR activity
Franz Ratzinger(Medical University of Vienna), Klaus G. Schmetterer(Medical University of Vienna)
Cited by 111
Related Papers
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
|Blood|2018|155
Biomarkers for differentiation of coronavirus disease 2019 or extracorporeal membrane oxygenation related inflammation and bacterial/fungal infections in critically ill patients: A prospective observational study
|Frontiers in Medicine|2022|4
Autoantibody development is associated with clinical severity of COVID-19: A cohort study
|Clinical Immunology|2025|3